Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry

Louise Redder; Tobias Wirenfeldt Klausen; Annette Juul Vangsted; Henrik Gregersen; Niels Frost Andersen; Robert Schou Pedersen; Torben Plesner; Mikael Frederiksen; Ulf Christian Frølund; Carsten Helleberg; Lene Kongsgaard Nielsen; Morten Salomo; Peter Gimsing; Henrik Frederiksen; Niels Abildgaard

doi:10.1182/blood-2019-128074

Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry

Louise Redder, Tobias Wirenfeldt Klausen, Annette Juul Vangsted, Henrik Gregersen, Niels Frost Andersen, Robert Schou Pedersen, Torben Plesner, Mikael Frederiksen, Ulf Christian Frølund, Carsten Helleberg, Lene Kongsgaard Nielsen, Morten Salomo, Peter Gimsing, Henrik Frederiksen, Niels Abildgaard

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	1849
Journal	Blood
Volume	134
Issue number	Supplement 1
ISSN	0006-4971
DOIs	https://doi.org/10.1182/blood-2019-128074
Publication status	Published - 13. Nov 2019
Event	American Society of Hematology: 61st Annual Meeting (ASH) - Orlando, United States Duration: 7. Dec 2019 → 10. Dec 2019

Conference

Conference	American Society of Hematology: 61st Annual Meeting (ASH)
Country/Territory	United States
City	Orlando
Period	07/12/2019 → 10/12/2019

Documents & Links

10.1182/blood-2019-128074

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Redder, L., Klausen, T. W., Vangsted, A. J., Gregersen, H., Andersen, N. F., Pedersen, R. S., Plesner, T., Frederiksen, M., Frølund, U. C., Helleberg, C., Kongsgaard Nielsen, L., Salomo, M., Gimsing, P., Frederiksen, H., & Abildgaard, N. (2019). Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry. Blood, 134(Supplement 1), Article 1849. https://doi.org/10.1182/blood-2019-128074

@article{13a161c31f8349b9aec17f0d62aef9a9,

title = "Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry",

author = "Louise Redder and Klausen, {Tobias Wirenfeldt} and Vangsted, {Annette Juul} and Henrik Gregersen and Andersen, {Niels Frost} and Pedersen, {Robert Schou} and Torben Plesner and Mikael Frederiksen and Fr{\o}lund, {Ulf Christian} and Carsten Helleberg and {Kongsgaard Nielsen}, Lene and Morten Salomo and Peter Gimsing and Henrik Frederiksen and Niels Abildgaard",

year = "2019",

month = nov,

day = "13",

doi = "10.1182/blood-2019-128074",

language = "English",

volume = "134",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "Supplement 1",

note = "American Society of Hematology: 61st Annual Meeting (ASH) ; Conference date: 07-12-2019 Through 10-12-2019",

}

Redder, L, Klausen, TW, Vangsted, AJ, Gregersen, H, Andersen, NF, Pedersen, RS, Plesner, T, Frederiksen, M, Frølund, UC, Helleberg, C, Kongsgaard Nielsen, L, Salomo, M, Gimsing, P, Frederiksen, H & Abildgaard, N 2019, 'Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry', Blood, vol. 134, no. Supplement 1, 1849. https://doi.org/10.1182/blood-2019-128074

Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry. / Redder, Louise; Klausen, Tobias Wirenfeldt; Vangsted, Annette Juul et al.
In: Blood, Vol. 134, No. Supplement 1, 1849, 13.11.2019.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry

AU - Redder, Louise

AU - Klausen, Tobias Wirenfeldt

AU - Vangsted, Annette Juul

AU - Gregersen, Henrik

AU - Andersen, Niels Frost

AU - Pedersen, Robert Schou

AU - Plesner, Torben

AU - Frederiksen, Mikael

AU - Frølund, Ulf Christian

AU - Helleberg, Carsten

AU - Kongsgaard Nielsen, Lene

AU - Salomo, Morten

AU - Gimsing, Peter

AU - Frederiksen, Henrik

AU - Abildgaard, Niels

PY - 2019/11/13

Y1 - 2019/11/13

U2 - 10.1182/blood-2019-128074

DO - 10.1182/blood-2019-128074

M3 - Conference abstract in journal

SN - 0006-4971

VL - 134

JO - Blood

JF - Blood

IS - Supplement 1

M1 - 1849

T2 - American Society of Hematology: 61st Annual Meeting (ASH)

Y2 - 7 December 2019 through 10 December 2019

ER -

Redder L, Klausen TW, Vangsted AJ, Gregersen H, Andersen NF, Pedersen RS et al. Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry. Blood. 2019 Nov 13;134(Supplement 1):1849. doi: 10.1182/blood-2019-128074